dan 2163 has been researched along with Depressive Disorder in 16 studies
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of amisulpride and olanzapine in subjects with schizophrenia and comorbid depression in a randomised double-blind trial." | 9.12 | A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression. ( Douki, S; Vanelle, JM, 2006) |
| "To determine the effectiveness of amisulpride on depression in patients with schizophrenia, in comparison to risperidone." | 9.12 | Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. ( Hwang, MY; Kim, JM; Kim, SW; Lee, JH; Lee, SH; Shin, IS; Yang, SJ; Yoon, BH; Yoon, JS, 2007) |
| " In a multicentre, 6 months, placebo-controlled trial, amisulpride (50 mg/daily) was compared to imipramine (100 mg/daily) in the treatment of patients with DSM-III-R criteria for primary dysthymia, dysthymia with major depression or major depression in partial remission." | 9.08 | Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. ( Boyer, P; Lecrubier, Y; Rein, W; Turjanski, S, 1997) |
| "To compare the efficacy and safety of amisulpride and olanzapine in subjects with schizophrenia and comorbid depression in a randomised double-blind trial." | 5.12 | A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression. ( Douki, S; Vanelle, JM, 2006) |
| "To determine the effectiveness of amisulpride on depression in patients with schizophrenia, in comparison to risperidone." | 5.12 | Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. ( Hwang, MY; Kim, JM; Kim, SW; Lee, JH; Lee, SH; Shin, IS; Yang, SJ; Yoon, BH; Yoon, JS, 2007) |
| " In a multicentre, 6 months, placebo-controlled trial, amisulpride (50 mg/daily) was compared to imipramine (100 mg/daily) in the treatment of patients with DSM-III-R criteria for primary dysthymia, dysthymia with major depression or major depression in partial remission." | 5.08 | Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. ( Boyer, P; Lecrubier, Y; Rein, W; Turjanski, S, 1997) |
| " The tolerability evaluation was based on incidence of adverse events and routine laboratory tests." | 2.70 | Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study. ( Cassano, GB; Jori, MC, 2002) |
| "The main objective was to identify the occurrence of adverse events associated with amisulpride when combined with antidepressants (ADs)." | 1.37 | Safety of amisulpride in combination with antidepressants under common clinical practice conditions. ( Ceskova, E; Priborska, Z; Suchopar, J, 2011) |
| "We report on a case of a patient with paranoid schizophrenia, who still presented negative and depressive symptoms during treatment with amisulpride for more than 6 weeks." | 1.33 | Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia. ( Burlon, M; Göhring, K; Gruschka, P; Kaiser, S; Pfüller, U; Roesch-Ely, D; Weisbrod, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uvais, NA | 1 |
| Gangadhar, P | 1 |
| Sreeraj, VS | 1 |
| Rafeeque, PA | 1 |
| Taoka, H | 1 |
| Hamamura, T | 1 |
| Endo, S | 1 |
| Miyata, S | 1 |
| Toma, K | 1 |
| Ishihara, T | 1 |
| Kuroda, S | 1 |
| Hwang, SS | 1 |
| Jung, DC | 1 |
| Ahn, YM | 1 |
| Kim, SH | 1 |
| Kim, YS | 1 |
| Ilett, KF | 1 |
| Watt, F | 1 |
| Hackett, LP | 1 |
| Kohan, R | 1 |
| Teoh, S | 1 |
| Ružić, K | 1 |
| Grahovac, T | 1 |
| Graovac, M | 1 |
| Dadić-Hero, E | 1 |
| Sepić-Grahovac, D | 1 |
| Sabljić, V | 1 |
| Ceskova, E | 1 |
| Suchopar, J | 1 |
| Priborska, Z | 1 |
| D'iakonov, AL | 1 |
| Lobanova, IV | 1 |
| Racagni, G | 1 |
| Canonico, PL | 1 |
| Ravizza, L | 1 |
| Pani, L | 1 |
| Amore, M | 2 |
| Kopecek, M | 1 |
| Bares, M | 1 |
| Horácek, J | 1 |
| Roesch-Ely, D | 1 |
| Göhring, K | 1 |
| Gruschka, P | 1 |
| Kaiser, S | 1 |
| Pfüller, U | 1 |
| Burlon, M | 1 |
| Weisbrod, M | 1 |
| Vanelle, JM | 1 |
| Douki, S | 1 |
| Kim, SW | 1 |
| Shin, IS | 1 |
| Kim, JM | 1 |
| Lee, SH | 1 |
| Lee, JH | 1 |
| Yoon, BH | 1 |
| Yang, SJ | 1 |
| Hwang, MY | 1 |
| Yoon, JS | 1 |
| León, CA | 1 |
| Vigoya, J | 1 |
| Conde, S | 1 |
| Campo, G | 1 |
| Castrillón, E | 1 |
| León, A | 1 |
| Lecrubier, Y | 1 |
| Boyer, P | 1 |
| Turjanski, S | 1 |
| Rein, W | 1 |
| Jori, MC | 2 |
| Cassano, GB | 1 |
1 review available for dan 2163 and Depressive Disorder
| Article | Year |
|---|---|
Consensus on the use of substituted benzamides in psychiatric patients.
Topics: Amisulpride; Antipsychotic Agents; Benzamides; Depressive Disorder; Humans; Mental Disorders; Schizo | 2004 |
6 trials available for dan 2163 and Depressive Disorder
| Article | Year |
|---|---|
A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depres | 2006 |
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Endp | 2007 |
[Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
Topics: Adolescent; Adult; Age Distribution; Amisulpride; Depressive Disorder; Double-Blind Method; Female; | 1994 |
Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group.
Topics: Adult; Aged; Amisulpride; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Depre | 1997 |
Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depressive Disord | 2001 |
Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents | 2002 |
9 other studies available for dan 2163 and Depressive Disorder
| Article | Year |
|---|---|
Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.
Topics: Aged; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Neuroleptic Malignant | 2019 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus St | 2008 |
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Cognition Disorders; Depressive | 2010 |
Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
Topics: Adult; Amisulpride; Antidepressive Agents; Breast Feeding; Cyclohexanols; Depressive Disorder; Desve | 2010 |
Hyperprolactinaemia with amisulpride.
Topics: Amisulpride; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Bo | 2011 |
Safety of amisulpride in combination with antidepressants under common clinical practice conditions.
Topics: Adult; Amisulpride; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; H | 2011 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benz | 2012 |
Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Hyperprolactinemia; M | 2005 |
Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dopamine Agonists; Drug | 2006 |